Free Trial
→ Trump’s Plan May Undo 1933’s Biggest Financial Injustice (From American Hartford Gold) (Ad)tc pixel

Short Interest in PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Rises By 24.5%

Written by MarketBeat
September 19, 2025
PureTech Health logo with Medical background

Key Points

  • Short interest in PureTech Health PLC Sponsored ADR increased by 24.5% in August, reaching 6,100 shares, indicating growing bearish sentiment among investors.
  • The stock has a current price of $14.86, with a fifty-two week range between $13.30 and $24.99.
  • Institutional investors and hedge funds now own 0.04% of PureTech Health shares, with notable new positions established by Millennium Management LLC and Diadema Partners LP.
  • MarketBeat previews the top five stocks to own by October 1st.

PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 6,100 shares, a growth of 24.5% from the August 15th total of 4,900 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 4,200 shares, the short-interest ratio is currently 1.5 days. Based on an average trading volume of 4,200 shares, the short-interest ratio is currently 1.5 days. Currently, 0.0% of the shares of the stock are short sold.

PureTech Health Stock Performance

NASDAQ:PRTC opened at $14.86 on Thursday. The company has a fifty day moving average of $17.79 and a two-hundred day moving average of $17.67. PureTech Health has a fifty-two week low of $13.30 and a fifty-two week high of $24.99.

Hedge Funds Weigh In On PureTech Health

Large investors have recently added to or reduced their stakes in the stock. Millennium Management LLC acquired a new position in PureTech Health during the fourth quarter worth $823,000. Diadema Partners LP acquired a new position in PureTech Health during the second quarter worth $126,000. Persistent Asset Partners Ltd acquired a new position in PureTech Health during the second quarter worth $29,000. Finally, Pentwater Capital Management LP raised its position in PureTech Health by 39.2% during the first quarter. Pentwater Capital Management LP now owns 33,560 shares of the company's stock worth $664,000 after acquiring an additional 9,449 shares during the period. 0.04% of the stock is currently owned by institutional investors and hedge funds.

About PureTech Health

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in PureTech Health Right Now?

Before you consider PureTech Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.

While PureTech Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.